James Mastrianni

26% fewer Medicare Part D claims than the average neurology physician in 2024

1,018 Medicare Part D claims for 253 beneficiaries, against an average of 1,370 among the 15,005 providers of this specialty who prescribed in Part D. Brand-name drugs were 5% of claims.

Most prescribed

1. Donepezil Hcl330 claims
2. Sertraline Hcl143 claims
3. Memantine Hcl137 claims
4. Quetiapine Fumarate65 claims
5. Trazodone Hcl42 claims
6. Galantamine Er32 claims

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

The MIPS final score for 2023 (Medicare payment program): 97.7 of 100

The Merit-based Incentive Payment System score is reported for this clinician. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.

Source: CMS Quality Payment Program, MIPS performance year 2023; category weights for 2023 (qpp.cms.gov).

Industry payments in 2024: $17.13

1 payment: food and beverage; the largest payer was Biogen, Inc. The 10,858 providers of this specialty with any payment received $8,318.07 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.

Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.

2 hospitals and group practices

1. The University OF Chicago Medical CenterChicago, IL · Acute Care Hospitals4 of 5 stars
2. University OF ChicagoChicago, IL

Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through); hospitals matched to CMS Hospital General Information (Care Compare) (data.cms.gov). Star ratings are CMS hospital ratings, not ratings of this provider.